Diagnostic HER2DX-guided treatment for patients with early-stage HER2-positive breast cancer

Project Information

DEFINITIVE

Grant agreement ID: 101136953

DOI

10.3030/101136953

EC signature date 11 December 2023

Start date 1 December 2023

End date 30 November 2028

Funded under

• Health

Total cost

€ 7 999 930,00

EU contribution

€ 7 999 930,00

Coordinated by

FUNDACIO DE RECERCA CLINIC BARCELONA-INSTITUT D INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER
Spain

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Deliverables

Documents, reports (7)

Conclusions of common annual meeting of the ‘Diagnostics and Treatment (diagnostics)’ cluster -1

Report on the conclusions of common annual meeting of the ‘Dianostics and Treatment’ cluster

Clinical guidelines

Summary of developped clinical guidelines based on DEFINITIVE project results - 1

Exploring patient experience in the HER2+ DEFINITIVE clinical trial: a qualitative study

Objectives and methods that will be used to collect DEFINITIVE trial patients experience.

Quality Assurance and Risk Management Plan

Document detailing the Quality Assurance and Risk Management Plan

Plan for ethic-legal monitoring

Document detailing the plan for ethic-legal monitoring & ethical submissions.

Dissemination and Communication Plan 1

Document describing the Dissemination and Communication Plan to ensure full exploitation of the project’s outputs and results.

Clinical guidelines 2

Summary of developped clinical guidelines based on DEFINITIVE project results - 2

Data Management Plan (1)

Data Management Plan 1

Document describing the management plan for DEFINITIVE project

Websites, patent fillings, videos etc. (1)

Project dedicated public website

DEFINITIVE webpage with public and private domains